Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury

BACKGROUND: Traumatic brain injury (TBI) is a major cause for long-term disability, yet the treatments available that improve outcomes after TBI limited. Neuroinflammatory responses are key contributors to determining patient outcomes after TBI. Transplantation of mesenchymal stem cells (MSCs), whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Peruzzaro, S. T., Andrews, M. M. M., Al-Gharaibeh, A., Pupiec, O., Resk, M., Story, D., Maiti, P., Rossignol, J., Dunbar, G. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320578/
https://www.ncbi.nlm.nih.gov/pubmed/30611291
http://dx.doi.org/10.1186/s12974-018-1383-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320578/
https://www.ncbi.nlm.nih.gov/pubmed/30611291
http://dx.doi.org/10.1186/s12974-018-1383-2

Ejemplares similares